These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23496229)

  • 21. Selection and characterization of DNA aptamers with binding selectivity to Campylobacter jejuni using whole-cell SELEX.
    Dwivedi HP; Smiley RD; Jaykus LA
    Appl Microbiol Biotechnol; 2010 Aug; 87(6):2323-34. PubMed ID: 20582587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel methods to detect cytokines by enzyme-linked oligonucleotide assay].
    Yan XR; Gao XW; Yao LH; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2004 Sep; 20(5):679-82. PubMed ID: 15973989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated microfluidic system for rapid screening of CRP aptamers utilizing systematic evolution of ligands by exponential enrichment (SELEX).
    Huang CJ; Lin HI; Shiesh SC; Lee GB
    Biosens Bioelectron; 2010 Mar; 25(7):1761-6. PubMed ID: 20061133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications of aptamers in cancer cell biology.
    Phillips JA; Lopez-Colon D; Zhu Z; Xu Y; Tan W
    Anal Chim Acta; 2008 Jul; 621(2):101-8. PubMed ID: 18573375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Research progress of aptamers application in molecular imaging].
    Ye Q; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1230-4. PubMed ID: 23469563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aptamer applications for targeted cancer therapy.
    Barbas AS; Mi J; Clary BM; White RR
    Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioapplications of Cell-SELEX-Generated Aptamers in Cancer Diagnostics, Therapeutics, Theranostics and Biomarker Discovery: A Comprehensive Review.
    Pang X; Cui C; Wan S; Jiang Y; Zhang L; Xia L; Li L; Li X; Tan W
    Cancers (Basel); 2018 Feb; 10(2):. PubMed ID: 29425173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of biomarkers and cell-specific molecular signatures: aptamers as capture agents.
    Nery AA; Wrenger C; Ulrich H
    J Sep Sci; 2009 May; 32(10):1523-30. PubMed ID: 19472283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays for aptamer-based platforms.
    Citartan M; Gopinath SC; Tominaga J; Tan SC; Tang TH
    Biosens Bioelectron; 2012 Apr; 34(1):1-11. PubMed ID: 22326894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aptamers-based assays for diagnostics, environmental and food analysis.
    Tombelli S; Minunni M; Mascini M
    Biomol Eng; 2007 Jun; 24(2):191-200. PubMed ID: 17434340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
    Li X; Zhao Q; Qiu L
    J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update: aptamers as novel radiopharmaceuticals: their applications and future prospects in diagnosis and therapy.
    Missailidis S; Perkins A
    Cancer Biother Radiopharm; 2007 Aug; 22(4):453-68. PubMed ID: 17803440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer modules as sensors and detectors.
    Famulok M; Mayer G
    Acc Chem Res; 2011 Dec; 44(12):1349-58. PubMed ID: 21819040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamer-based biosensors for biomedical diagnostics.
    Zhou W; Huang PJ; Ding J; Liu J
    Analyst; 2014 Jun; 139(11):2627-40. PubMed ID: 24733714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents.
    Kumar Kulabhusan P; Hussain B; Yüce M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32659966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer cell targeting using multiple aptamers conjugated on nanorods.
    Huang YF; Chang HT; Tan W
    Anal Chem; 2008 Feb; 80(3):567-72. PubMed ID: 18166023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simple Methods and Rational Design for Enhancing Aptamer Sensitivity and Specificity.
    Kalra P; Dhiman A; Cho WC; Bruno JG; Sharma TK
    Front Mol Biosci; 2018; 5():41. PubMed ID: 29868605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aptamer-iRNAs as Therapeutics for Cancer Treatment.
    Soldevilla MM; Meraviglia-Crivelli de Caso D; Menon AP; Pastor F
    Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30340426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aptamer Cell-Based Selection: Overview and Advances.
    Catuogno S; Esposito CL
    Biomedicines; 2017 Aug; 5(3):. PubMed ID: 28805744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.